Group One Trading
TARS icon

Group One Trading’s Tarsus Pharmaceuticals TARS Stock Holding History

Group One Trading’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,163
Closed -$69.1K – 9135
2025
Q3 		$69.1K Buy
1,163
+1,005
+636% +$49.5K ﹤0.01% 5689
2025
Q2 		$6.4K Sell
158
-413
-72% -$18.6K ﹤0.01% 6970
2025
Q1 		$29.3K Buy
+571
New +$28.2K ﹤0.01% 5553

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Group One Trading's TARS Position: Q4 2025 in Review

Group One Trading sold out of Tarsus Pharmaceuticals (TARS) in Q4 2025, closing a stake of 1,163 shares — an estimated $69.1K sold.

Group One Trading first reported a position in TARS in Q1 2025 and held it in 3 quarters. The position peaked at $69.1K in Q3 2025. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • Group One Trading reported no remaining Tarsus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 1,163 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $69.1K.
  • Group One Trading first reported a position in Tarsus Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Group One Trading's Tarsus Pharmaceuticals position peaked at $69.1K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.